Hybrid Technology Hub researcher Jo Waaler is awarded a grant of 4,4 million NOK for the project Tankyrase Inhibition in Cancer Immunotherapy. The grant is awarded by Helse Sør Øst.
Ann Lin is a Fulbright scholar from the United States who joined the centre in August. At the Hybrid Technology Hub, Ann hopes to combine mass spectrometry technology, organoids, and organ-on-CHIP technology to create a pipeline to measure patient response to drugs.
Adipose derived stem cells (ASCs) are currently being investigated for a number of uses in regenerative medicine, but potential clinical use would require a robust method capable of producing a high number of cells.
In this article, Scholz Group member and PhD student Simen W. Schive et al. describe a method for large scale production of ASCs using automated systems, a workflow that could be used for future clinical trials. The manuscript was selected for the cover page in the current issue of CellR4.
At the Oslo University Hospital, HTH researcher Dr. Hanne Scholz is testing 3D-printing technology in an attempt to cure patients with diabetes type 1.
The Steven Wilson and Stefan Krauss-led project, Organ-on-chip connected to mass spectrometry: An efficient tool for developing and testing drugs was awarded in the category for student-active research.
Jo Waaler and Stefan Krauss are one of six new SPARK teams at UiO: Life Sciences
